-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $5

Benzinga·03/06/2026 13:08:07
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $10 to $5.